Journal article

Chimeric antigen receptor T-cell therapy for haematological malignancies

Adrian G Selim, Constantine S Tam

The Medical Journal of Australia | WILEY | Published : 2020

Funding Acknowledgements

Adrian Selim has received honoraria from Novartis. Constantine Tam was a principal investigator on the JULIET study sponsored by Novartis, and receives research funding from Janssen and AbbVie, and honoraria from Janssen, AbbVie, BeiGene, Novartis and Roche.